Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

Secondary Hyperparathyroidism Clinical Trial

Official title:

Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03137316
• Other study ID #: BN-0418
• Status: Completed
• Phase: N/A
• First received: April 28, 2017
• Last updated: May 1, 2017
• Start date: January 1, 2014
• Est. completion date: March 1, 2017

Study information

• Verified date: May 2017
• Source: Benha University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to evaluate the prevalence of secondary hyperparathyroidism among patients with diabetic nephropathy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 437
• Est. completion date: March 1, 2017
• Est. primary completion date: February 28, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• [1] Age was above 18 years, [2] Patient had diabetic nephropathy which was diagnosed based on the presence of urinary albumin/creatinine ratio (uACR) = 30 mg/gm ± 24 hours' urinary protein measurement = 300 mg/day

Exclusion Criteria:

• [1] patients were already receiving cinacalcet and/or [2] patients had undergone neck surgery for parathyroidectomy.

Related Conditions & MeSH terms

• Diabetic Nephropathies
• Hyperparathyroidism
• Hyperparathyroidism, Secondary
• Kidney Diseases
• Neoplasm Metastasis
• Secondary Hyperparathyroidism

Intervention

Diagnostic Test:
• intact parathyroid hormone level
obtain intact parathyroid hormone level from patients records.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Benha University	New Jeddah Clinic Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	intact parathyroid level	intact parathyroid level	within 1 hour from attending in the clinic